image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 44.61
-0.999 %
$ 2.14 B
Market Cap
14.82
P/E
INCOME STATEMENT
644 M REVENUE
29.14%
197 M OPERATING INCOME
150.12%
138 M NET INCOME
50.51%
EFFICIENCY
Earnings Waterfall Amphastar Pharmaceuticals, Inc.
image
Revenue 644 M
Cost Of Revenue 300 M
Gross Profit 344 M
Operating Expenses 154 M
Operating Income 197 M
Other Expenses 59.4 M
Net Income 138 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 644.4 499.0 437.8 349.8 322.4 294.7 240.2 255.2 251.5 210.5 229.7 204.3 118.4
GROSS PROFIT
Cost Of Revenue 300.4 250.1 238.0 206.5 190.4 187.7 149.4 151.0 174.2 159.2 142.7 114.0 90.3
Gross Profit 344.0 248.9 199.7 143.3 131.9 107.0 90.8 104.2 77.3 51.3 87.0 90.3 28.1
OPERATING INCOME
Operating Expenses 154.1 141.4 129.9 132.4 132.0 115.6 94.3 88.5 84.0 68.8 69.3 62.8 61.6
Selling, General and Administrative Expenses 80.4 66.6 68.9 65.2 63.1 58.0 50.9 47.3 47.0 40.4 36.3 31.6 30.5
Research and Development Expenses 73.7 74.8 60.9 67.2 68.9 57.6 43.4 41.2 37.1 28.4 33.0 31.2 31.0
Operating Income 197.0 78.8 43.1 (14.2) 39 K (8.6) (0.9) 15.7 (6.9) (18.0) 17.5 25.4 (33.5)
PRE-TAX INCOME
Interest Income Expense 27.2 1.8 0.9 0.4 0.1 0.2 0.8 1.0 1.0 0.6 1.0 0.8 0.6
Total Other Income (25.6) 8.5 14.3 (6.3) 60.3 (1.3) 2.5 (0.7) (3.5) (0.2) (0.3) (1.6) 1.7
Pre-Tax Income 171.4 116.0 84.1 4.6 60.2 (9.9) 1.6 14.9 (10.4) (18.1) 17.2 25.9 (31.9)
NET INCOME
Tax Provision 31.8 23.5 20.6 3.5 13.7 (3.3) (2.9) 4.4 (7.6) (7.4) 5.4 7.8 (39.6)
Net Income 137.5 91.4 62.1 1.1 48.9 (5.7) 4.5 10.5 (2.8) (10.7) 11.9 18.1 7.8
EPS 2.85 1.88 1.3 0.0233 1.04 0.12 0.1 0.23 0.062 0.25 1.48 2.26 0.97